Oncternal Therapeutics, Inc. (ONCT) Financials
Stock symbol ONCT is outdated, potentially delisted? Maybe it is available on other exchange?
ONCT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2024 | 15.6 million | 6.5 million |
| June 30, 2024 | 23.9 million | 8.1 million |
| March 31, 2024 | 29.1 million | 6.2 million |
| Dec. 31, 2023 | 36.7 million | 6.7 million |
ONCT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2024 | -7.0 million | 1.9 million |
| June 30, 2024 | -5.8 million | 1.4 million |
| March 31, 2024 | -7.4 million | 1.4 million |
| Dec. 31, 2023 | -6.4 million | 2.2 million |
ONCT Net Income
No data available :(
ONCT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2024 | 14.6 million | - | - |
| June 30, 2024 | 21.4 million | 50000 | 50000 |
| March 31, 2024 | 27.0 million | 99000 | 99000 |
| Dec. 31, 2023 | 34.3 million | 145000 | 145000 |
ONCT Shares Outstanding
ONCT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2024 | - | 6.4 million | 2.7 million | - |
| June 30, 2024 | - | 6.6 million | 3.1 million | 25000 |
| March 31, 2024 | - | 6.1 million | 3.3 million | - |
| Dec. 31, 2023 | - | 6.7 million | 3.3 million | - |
ONCT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2024 | - | - |
| June 30, 2024 | 801000 | 5.9 million |
| March 31, 2024 | 569000 | 6.1 million |
| Dec. 31, 2023 | 297000 | 6.7 million |
ONCT
Price: $0.53
52 week price:
Payout Ratio Range:
Earnings Per Share: -11.69 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 91400
Market Capitalization: 1.6 million